WorldCat Identities

Krogh-Madsen, Rikke

Works: 4 works in 4 publications in 1 language and 6 library holdings
Roles: Other, Contributor
Publication Timeline
Most widely held works by Rikke Krogh-Madsen
A randomized controlled trial on a multicomponent intervention for overweight school-aged children - Copenhagen, Denmark by Nina Majlund Harder-Lauridsen( )

1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide

Glucose Metabolism in Critically Ill Patients( )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Critical illness afflicts millions of people worldwide and is associated with a high risk of organ failure and death or an adverse outcome with persistent physical or cognitive deficits. Spontaneous hyperglycemia is common in critically ill patients and is associated with an adverse outcome compared to normoglycemia. Insulin is used for treating hyperglycemia in the critically ill patients but may be complicated by hypoglycemia, which is difficult to detect in these patients and which may lead to serious neurological sequelae and death. The incretin hormone, glucagon-like peptide (GLP) 1, stimulates insulin secretion and inhibits glucagon release both in healthy individuals and in patients with type 2 diabetes (T2DM). Compared to insulin, GLP-1 appears to be associated with a lower risk of severe hypoglycemia, probably because the magnitude of its insulinotropic action is dependent on blood glucose (BG). This is taken advantage of in the treatment of patients with T2DM, for whom GLP-1 analogs have been introduced during the recent years. Infusion of GLP-1 also lowers the BG level in critically ill patients without causing severe hypoglycemia. The T2DM and critical illness share similar characteristics and are, among other things, both characterized by different grades of systemic inflammation and insulin resistance. The GLP-1 might be a potential new treatment target in critically ill patients with stress-induced hyperglycemia
Intermittent Standing but not a Moderate Exercise Bout Reduces Postprandial Glycemia( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

ABSTRACT: Purpose: This study aimed to determine whether minimum recommended moderate-to-vigorous physical activity (MVPA; 30-min bout of continuous moderate-intensity walking) is sufficient to counteract the detrimental effects of prolonged sitting on postprandial metabolism and if there are any effects of breaking up sitting with intermittent standing when achieving minimum recommended MVPA. Methods: Fourteen ( n = 14) physically inactive healthy adult males underwent four intrahospital 27-h interventions: 9-h continuous sitting (SIT), 15-min standing bouts every 30 min during the 9-h sitting (STAND), 30-min moderate-intensity walking bout followed by 8.5 h of sitting (MVPA), and 30-min moderate-intensity walking bout followed by 15-min standing bouts every 30 min during 8.5 h of sitting (MVPA + STAND). Three standardized meals on intervention day (day 1) and breakfast the following day (day 2) were served. Results: Cumulative postprandial glucose response (incremental area under the curve) was lower in STAND versus SIT (↓27%, P = 0.04, effect size [ES] = −0.7) because of decreases in postprandial glucose after breakfast on day 1 (STAND vs SIT: ↓40%, P = 0.01, ES = −0.7) and day 2 (STAND vs SIT: ↓33%, P = 0.06, ES = −0.6). STAND did not affect postprandial insulin responses. Cumulative postprandial insulin response was lower in MVPA versus SIT (↓18%, P = 0.03, ES = −0.3) and MVPA + STAND versus SIT (↓26%, P = 0.02, ES = −0.4) because of expected exercise-induced decreases in postprandial insulin after breakfast on day 1 only (MVPA vs SIT: ↓36%, P = 0.003, ES = −0.7; MVPA + STAND vs SIT: ↓43%, P = 0.0001, ES = −0.8). Conclusion: Breaking up prolonged sitting with nonambulatory standing across 9 h acutely reduced postprandial glycemic response during and the day after the intervention independent of insulin levels, whereas a 30-min MVPA bout did not. Abstract : Supplemental digital content is available in the text
Audience Level
Audience Level
  General Special  
Audience level: 0.94 (from 0.88 for Intermitte ... to 0.97 for A randomiz ...)

Alternative Names
Madsen, Rikke Krogh